How many investments has InnoCom Bio Equities made?

InnoCom Bio Equities has 11 tracked investments.

What stage does InnoCom Bio Equities invest at?

InnoCom Bio Equities invests at the Pre-Seed, Seed, Series A stages.

What sectors does InnoCom Bio Equities focus on?

InnoCom Bio Equities focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.

Where is InnoCom Bio Equities located?

InnoCom Bio Equities is headquartered in San Francisco, US.

InnoCom Bio Equities

Venture capital

San Francisco · Pre-Seed–Series A · 9 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into InnoCom Bio Equities

134 people in our graph share verified history with the InnoCom Bio Equities team — schools, employers, funds. One of them is your warm intro.

Garry Tanunlockedknows Mary Patton · together at Initialized Capital (overlapped)

×8knows the team · via Initialized Capital

knows the team · via UCB

×2knows the team · via Macy's

✨ Fox Verdict

Investment thesis

The firm structures portfolio-based investments in life sciences technologies through special purpose vehicles, aiming to reduce risk via diversification across multiple technologies. It provides seed capital to innovators and founders, emphasizes early commercialization opportunities, and seeks to expedite value creation. The approach targets exclusive intellectual property with royalty and out-licensing potential, and works to create synergies by securing multiple technologies within a single portfolio.

Invests inBiotech Digital Health Healthtech Longevity Medical Devices San Francisco United States

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Series A

San Francisco, CA, US

Instruments

Equity

Tracked investments

Team · 9 people

from the firm's website

Jack E. Doty· Chief Executive Officer

Co-founder of InnoCom Bio Equities and managing member of Metro Pacific BDS. A finance executive with past leadership roles including managing director for finance at Esperance Private Equity, CEO/chair of Halo Confections, and CFO/vice chair of Granny Goose Foods.

Joel Ehrenzweig· Co-Founder

A veterinarian (DVM, MRCVS) and co-founder of InnoCom Bio Equities. Founder and CEO of Veterinary Health Research Centers and founder of several certified US animal health hospitals, with executive experience at contract research organizations.

Jules D'Assonville· Co-Founder· Queensland, Australiain

Veterinary medicine professional and co-founder of InnoCom Bio. Founded Pacific AgVet and serves as proprietor of Pacific AH Consulting, with additional co-founder roles at Kiah Bio, Sprint Health, and Bilby BioPure.

Jules D’Assonville· Co-Founder

A veterinarian (DVM) and founder of Pacific AgVet and Pacific AH Consulting, with co-founder roles at Kiah Bio, Sprint Health, and Bilby BioPure.

Kamlesh Doshi· Managing Director for Affiliations

Co-founder of 3I'SVIEW, INC. and Beaute Innovations LLC, with a background in sales, SAP consulting, and finance/capital markets roles at institutions including Bank of America and Security Pacific Bank.

Mary Patton· Scientific Advisory Board· Austin, Texas, United Statesin

Executive director at Phoenix Biotechnology Inc. and a member of the scientific and business advisory boards, with 28 years in life science and product launch experience at UCB, LifeWatch, Daiichi Sankyo, and Abbott.

Mathias Hausherr· Business Advisory Board

Business advisory board member; CEO and co-founder of Fintegrate Consulting and managing partner at Transatlantic Partners Group, with two decades of management consulting focused on Swiss companies expanding into the US.

Steve Gullans· Business Advisory Board

Business advisory board member and managing director at Excel Venture Management, a venture investor who managed a $225M fund across 40+ life science companies and a former Harvard Medical School professor.

Tamas Gorbe· Scientific Advisory Board

Scientific advisory board member; COO and co-founder of Menten AI (Y Combinator W20), with postdoctoral bioinformatics research at KTH Royal Institute of Technology and a research scholarship at Caltech.

Investments · 11 tracked

founders shown can be your intro path

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Anti-Microbe SolutionAntibiotic Resistant Infection Management & Wound CareBiopharmaceutical ProductionDamaged Lung TherapeuticsHeart FailureHeart Failure (Restrictive Cardiomyopathy)Large Burn and Blast Skin ReplacementLive-Attenuated Replication-Competent Herpes SolutionOvarian & Esophageal CancersSmall-molecule Anti-cancer TherapeuticTemporary Blood Substitute

Frequently asked questions

How many investments has InnoCom Bio Equities made?: InnoCom Bio Equities has 11 tracked investments.
What stage does InnoCom Bio Equities invest at?: InnoCom Bio Equities invests at the Pre-Seed, Seed, Series A stages.
What sectors does InnoCom Bio Equities focus on?: InnoCom Bio Equities focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
Where is InnoCom Bio Equities located?: InnoCom Bio Equities is headquartered in San Francisco, US.

Images

Similar investors

Khosla Ventures

Khosla Ventures is a venture capital firm founded by Vinod Khosla.

$5K – $50M

Illumina Ventures

Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.

Medical Excellence Capital

Medical Excellence Capital (MEC) is a venture firm focused on precision health and life sciences, pairing investment professionals and operators with a proprietary national medical network platform.

Mission Biocapital

Mission BioCapital provides early-stage capital and shared lab space to life science entrepreneurs, supporting companies from idea through clinic and exit.

$500K

Novo Holdings

Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.

$1.1M – $54M